Charles River Laboratories International (CRL) Long-Term Deferred Tax (2010 - 2025)

Charles River Laboratories International (CRL) has reported Long-Term Deferred Tax for 16 consecutive years, with $67.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Long-Term Deferred Tax rose 59.64% year-over-year to $67.3 million; the TTM figure through Dec 2025 stood at $67.3 million (up 59.64% YoY), while the FY2025 annual figure was $67.3 million, up 59.64% from the prior year.
• Long-Term Deferred Tax came in at $67.3 million for Q4 2025 at Charles River Laboratories International, up from $36.9 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $67.3 million in Q4 2025, with the low at $31.9 million in Q2 2021.
• Average Long-Term Deferred Tax over 5 years is $41.1 million, with a median of $40.3 million recorded in 2021.
• Across the five-year window, Long-Term Deferred Tax declined 25.48% in 2021 and jumped 59.64% in 2025, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $40.2 million in 2021, then advanced by 2.58% to $41.3 million in 2022, then declined by 2.38% to $40.3 million in 2023, then increased by 4.72% to $42.2 million in 2024, then surged by 59.64% to $67.3 million in 2025.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $67.3 million, $36.9 million, and $46.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.